- 全部删除
您的购物车当前为空
Magrolimab (Hu5F9-G4) 是一种人源化抗 CD47 IgG4 单克隆抗体,通过阻断CD47来展现其抗肿瘤活性,主要与CD47的 N 末端焦谷氨酸结合,可用于和其他化合物联合治疗复发性骨髓瘤。

Magrolimab (Hu5F9-G4) 是一种人源化抗 CD47 IgG4 单克隆抗体,通过阻断CD47来展现其抗肿瘤活性,主要与CD47的 N 末端焦谷氨酸结合,可用于和其他化合物联合治疗复发性骨髓瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,880 | In stock | |
| 5 mg | ¥ 4,560 | In stock | |
| 10 mg | ¥ 6,630 | In stock | |
| 25 mg | ¥ 9,850 | 5日内发货 | |
| 50 mg | ¥ 13,200 | 5日内发货 |
| 产品描述 | Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits its antitumor activity by blocking CD47 and binds primarily to the N-terminal pyroglutamate of CD47, and can be used in combination with other compounds for the treatment of recurrent myeloma. |
| 别名 | 莫洛利单, Magrolimab (anti-CD47), Hu5F9-G4 |
| CAS No. | 2169232-81-7 |
| 密度 | no data available |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容